Experimental treatment for Niemann-Pick disease appears safe

Por um escritor misterioso

Last updated 12 junho 2024

An experimental drug has appeared to slow the progression of Niemann-Pick disease the drug 2-hydroxypropyl-beta-cyclodextrin is being tested

Autumn 2009 - the Niemann-Pick Disease Group (UK)

Familial Hypercholesterolemia: From Clinical Suspicion to Novel Treatments

Niemann-Pick Disease, A Pipeline Analysis Report 2018, Technavio

Niemann-Pick disease A or B in four pediatric patients and SMPD1 mutation carrier frequency in the Mexican population

Enhanced Delivery and Effects of Acid Sphingomyelinase by ICAM-1-Targeted Nanocarriers in Type B Niemann-Pick Disease Mice - ScienceDirect

Frontiers c-Abl Activation Linked to Autophagy-Lysosomal Dysfunction Contributes to Neurological Impairment in Niemann-Pick Type A Disease

Emerging Startups Take Aim at Lysosomal Storage Disorders

Potential pharmacological strategies targeting the Niemann-Pick C1 receptor and Ebola virus glycoprotein interaction - ScienceDirect

Newborn screening test developed for rare, deadly neurological disorder – Washington University School of Medicine in St. Louis

Health Tip on New Treatment that Shows Promise in Niemann-Pick Type C Disorder - Health Tips

Adenosine A2A receptor stimulation restores cell functions and differentiation in Niemann-Pick type C-like oligodendrocytes

Families plead with FDA for drug to treat Niemann-Pick Disease Type C

Niemann-Pick Disease, A Pipeline Analysis Report 2018, Technavio

Recomendado para você